Medidata Selected for Fortune 100 Fastest-Growing Companies List
NEW YORK--(BUSINESS WIRE)--Aug 23, 2018--In recognition of three record-performing years, Medidata (NASDAQ: MDSO) was selected for Fortune’s 100 Fastest-Growing Companies list. Fortune ranked Medidata a top performer in consecutive years.
The annual Fortune list recognizes top three-year performers in revenues, profits, and stock returns. The ranking provides a snapshot of the trends driving the global economy, including the continued dominance of the technology sector.
“Our cloud platform is powering the development of the majority of breakthrough drug therapies on the market today,” said Tarek Sherif, chairman and chief executive officer, Medidata. “Our inclusion in this list of high performing companies shows how the life science industry is embracing our unified platform, which closes the loop between clinical and commercial. We’re proud of our role helping to bring life saving therapies to patients around the world.”
The Intelligent Platform for Life Sciences is leading the digital transformation of life sciences with artificial intelligence and advanced analytics. Medidata is the strategic partner for more than 1,000 customers worldwide and is accelerating the discovery of new therapies for patients in need.
Medidata is leading the digital transformation of life sciences, with the world’s most used platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by the #1 ranked industry experts, the Intelligent Platform for Life Sciences helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata serves more than 1,000 customers and partners worldwide and empowers more than 100,000 certified users every day to create hope for millions of patients. Discover the future of life sciences: www.mdsol.com
View source version on businesswire.com:https://www.businesswire.com/news/home/20180823005372/en/
Betsy Frank, +1 917-522-4620
Erik Snider, +1 646-362-2997
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT HEALTH BIOTECHNOLOGY PHARMACEUTICAL RESEARCH SCIENCE
Copyright Business Wire 2018.
PUB: 08/23/2018 08:35 AM/DISC: 08/23/2018 08:36 AM